Aurora Innovation financials
$5.39+1.89%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $3.0M | $0.00 | $0.00 | $68.0M | $82.0M |
| Gross profit | -$14.0M | $0.00 | $0.00 | $68.0M | $82.0M |
| Gross margin | −466.7% | — | — | 100.0% | 100.0% |
| Operating income | -$901.0M | -$786.0M | -$835.0M | -$1.85B | -$731.0M |
| Net income | -$816.0M | -$748.0M | -$796.0M | -$1.72B | -$755.0M |
| Net margin | −27200.0% | — | — | −2533.8% | −920.7% |
| Diluted EPS | $-0.44 | $-0.46 | $-0.60 | $-1.51 | $-1.22 |
| EBITDA | -$871.0M | -$765.0M | -$814.0M | -$716.0M | -$715.0M |
| Operating cash flow | -$581.0M | -$611.0M | -$598.0M | -$508.0M | -$564.0M |
| Free cash flow | -$612.0M | -$645.0M | -$613.0M | -$523.0M | -$612.0M |
| Diluted shares | 1,839.0M | 1,618.0M | 1,327.0M | 1,143.0M | 621.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $221.0M | $211.0M | $501.0M | $262.0M | $1.61B |
| Short-term investments | $1.05B | $1.01B | $699.0M | $839.0M | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $2.34B | $2.14B | $2.23B | $2.00B | $3.69B |
| Total liabilities | $203.0M | $263.0M | $250.0M | $217.0M | $348.0M |
| Shareholders' equity | $2.14B | $1.88B | $1.99B | $1.78B | $3.34B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology